Activity Post Test and Evaluation Form

Post Test

Please note that to receive credit you must achieve a score of at least 70%.

Pharmacists: The information that you participated will be uploaded to CPE Monitor and you will be able to access your credits from the profile you set up with NABP. For more information, please visit http://www.nabp.net/.

Question Title

* 1. The most common route of opioid abuse is:

Inhalation

Ingestion

Injection

Smoking

Question Title

* 2. Which of the following is an immediate-release opioid with abuse-deterrent technology?

OxyContin®

RoxyBond®

Ventrela®

Hysingla®

Question Title

* 3. Current abuse-deterrent technologies cannot prevent:

Ingestion of supratherapeutic doses of non-manipulated product

Crushing of tablets to fine powder for snorting

Dissolving the opioid to be drawn into a syringe for injection

Extraction of the opioid by water or alcohol

Question Title

* 4. An opioid antagonist that is used in abuse-deterrent formulations is:

Naltrexone

Disulfiram

Acamprosate

Bupropion

Question Title

* 5. The act of selling a portion of an opioid prescription to another individual best describes opioid:

Abuse

Misuse

Diversion

Manipulation

Question Title

* 6. Since 2011, the number of opioid prescriptions in the US has trended downward.

True

False

Question Title

* 7. Abuse-deterrent is same as abuse-proof:

True

False